Startup’s tablets deliver cancer drugs more evenly over time
An MIT team’s technology could allow cancer drugs to be delivered more steadily into the bloodstream, to improve effectiveness and reduce side effects.
An MIT team’s technology could allow cancer drugs to be delivered more steadily into the bloodstream, to improve effectiveness and reduce side effects.
Twelve START.nano companies competed for the grand prize of nanoBucks to be used at MIT.nano’s facilities.
MIT postdoc Giorgio Rizzo harnesses plant chemistry to design sustainable fertilizers that could reshape modern farming.
Co-founded by an MIT alumnus, Watershed Bio offers researchers who aren’t software engineers a way to run large-scale analyses to accelerate biology.
Panel discussions focused on innovation in many forms of energy, then a tour of campus featured student research.
Bakshi will help shape and scale entrepreneurship education and platform at MIT.
This year’s delta v summer accelerator offered an up-close look at how AI is changing the process of building a startup.
The gathering of Biogen and MIT employees, business leaders, and public officials celebrated the first building to be constructed at Kendall Common.
Cache DNA has developed technologies that can preserve biomolecules at room temperature to make storing and transporting samples less expensive and more reliable.
A system conceived in Professor Michael Cima’s lab was approved by the Food and Drug Administration after positive results in patients.
MIT student teams celebrate business milestones at the capstone event for the 2025 delta v summer accelerator.
Ianacare, co-founded by Steven Lee ’97, MEng ’98, equips caregivers with the resources, networks, and tools they need to support loved ones.
Through education and innovation, the new initiative aims to spark novel approaches to global sustainability challenges and strengthen academic ties.
Storage systems from Cloudian, co-founded by an MIT alumnus, are helping businesses feed data-hungry AI models and agents at scale.
MIT spinout Tissium recently secured FDA marketing authorization of a biopolymer platform for nerve repair.